In the perspective of investigating, as a further step, potential correlation with the prognosis, the purpose of this study is the use of the CEACAM3 blood expression, as index of the amount of CTCs, to evaluate its trend at different times in the perioperative course of CRC. Here, CEACAM3 is linked to colorectal carcinoma.